Overview
1
-
Debiopharm is a Swiss biopharmaceutical company founded in 1979, headquartered in Lausanne, Switzerland. The group operates across three areas: drug development (oncology and infectious diseases, via Debiopharm International SA), drug manufacturing (via Debiopharm Research & Manufacturing), and digital health investment (via Debiopharm Innovation Fund, which invests in AI-driven and data-powered healthcare startups). Debiopharm is privately owned and focuses on developing innovative treatments for unmet medical needs alongside building the future of digital health.
Stages
3
Sectors
6
Geographic focus
2
Portfolio companies
1
Companies from this investor’s TAAFT profile, ranked by latest known raise. Round details come from our company catalog.
- Companies
- 1
- Latest raises tracked
- $4.9M
- With round data
- 1
- Stages seen
- Seed
-
Seed Announced 8 investors
- Valuation
- $25M
